Funding for this research was provided by:
Florida Department of Health (22A17)
National Institute of Health (R56AG069676)
National Institute of Health (R56AG064075)
National Institute of Health (RF1AG071762)
National Institute of Health (R21AG072379)
National Institute of Health (U01AG076928)
Article History
Received: 11 January 2023
Accepted: 1 August 2023
First Online: 10 August 2023
Declarations
:
: None of the authors report any conflict of interest related to this work. HY is Co-founder and Chief Scientific Officer of Postbiotics Inc and SJ is founder of MusB LLC, but their roles have no conflict and influence with the work presented in this manuscript.